BEAM Beam Therapeutics
- 33.140
- +0.970+3.02%
- 33.140
- 0.0000.00%
Beam Therapeutics News
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
Beam Therapeutics Inc. (NASDAQ:BEAM) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Beam Therapeutics Gains as H.C. Wainwright Starts at Buy
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Express News | Beam Therapeutics Shares Are Trading Higher After HC Wainwright & Co. Initiated Coverage on the Stock With a Buy Rating and Announced an $80 Price Target
Beam Therapeutics Initiated at Buy by HC Wainwright & Co.
Beam Therapeutics Analyst Ratings
H.C. Wainwright Initiates Beam Therapeutics(BEAM.US) With Buy Rating, Announces Target Price $80
Express News | Beam Therapeutics Inc. : H.c. Wainwright Initiates Coverage With Buy Rating
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
Beam Therapeutics' (BEAM) CFO to Step Down, Stock Declines
J.P. Morgan Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $45
Beam Therapeutics Shares Fall After News of CFO Departure
Beam Therapeutics Has Initiated A Search For A New CFO After Terry-Ann Burrell Shared Plans To Depart On August 9 To Join JPMorgan Chase
Beam Therapeutics Has Initiated a Search for a Successor >BEAM
Express News | Beam Therapeutics Inc - CFO Terry-Ann Burrell to Leave August 9, 2024
Express News | Beam Therapeutics Announces Transition of Chief Financial Officer
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
Beam Therapeutics (BEAM) Upgraded to Buy: What Does It Mean for the Stock?
Analysis
Price Target
No Data
